Allworth Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.38M | Sell |
32,432
-25,735
| -44% | -$1.4M | 0.01% | 625 |
|
|
2026
Q1 | $3.65M | Buy |
58,167
+11,989
| +26% | +$959K | 0.01% | 412 |
|
|
2025
Q4 | $4.4M | Buy |
46,178
+6,084
| +15% | +$596K | 0.02% | 376 |
|
|
2025
Q3 | $3.91M | Buy |
40,094
+1,133
| +3% | +$117K | 0.02% | 366 |
|
|
2025
Q2 | $4.18M | Buy |
38,961
+26,623
| +216% | +$2.69M | 0.02% | 340 |
|
|
2025
Q1 | $1.25M | Buy |
12,338
+1,094
| +10% | +$110K | 0.01% | 483 |
|
|
2024
Q4 | $1.13M | Buy |
11,244
+2,815
| +33% | +$248K | 0.01% | 508 |
|
|
2024
Q3 | $706K | Buy |
8,429
+104
| +1% | +$8.2K | ﹤0.01% | 506 |
|
|
2024
Q2 | $646K | Buy |
8,325
+2,673
| +47% | +$196K | ﹤0.01% | 516 |
|
|
2024
Q1 | $387K | Buy |
5,652
+170
| +3% | +$10.9K | ﹤0.01% | 616 |
|
|
2023
Q4 | $317K | Buy |
5,482
+591
| +12% | +$31.5K | ﹤0.01% | 630 |
|
|
2023
Q3 | $258K | Buy |
4,891
+229
| +5% | +$12K | ﹤0.01% | 633 |
|
|
2023
Q2 | $252K | Buy |
4,662
+88
| +2% | +$4.6K | ﹤0.01% | 642 |
|
|
2023
Q1 | $229K | Buy |
4,574
+553
| +14% | +$26.1K | ﹤0.01% | 621 |
|
|
2022
Q4 | $186K | Buy |
4,021
+486
| +14% | +$21K | ﹤0.01% | 652 |
|
|
2022
Q3 | $137K | Buy |
3,535
+752
| +27% | +$30.2K | ﹤0.01% | 683 |
|
|
2022
Q2 | $104K | Buy |
2,783
+350
| +14% | +$14.2K | ﹤0.01% | 703 |
|
|
2022
Q1 | $108K | Buy |
2,433
+864
| +55% | +$37.4K | ﹤0.01% | 707 |
|
|
2021
Q4 | $67K | Sell |
1,569
-460
| -23% | -$19.3K | ﹤0.01% | 773 |
|
|
2021
Q3 | $88K | Buy |
2,029
+380
| +23% | +$16.8K | ﹤0.01% | 640 |
|
|
2021
Q2 | $71K | Buy |
1,649
+115
| +7% | +$4.84K | ﹤0.01% | 539 |
|
|
2021
Q1 | $59K | Hold |
1,534
| – | – | ﹤0.01% | 536 |
|
|
2020
Q4 | $55K | Sell |
1,534
-4
| -0.3% | -$144 | ﹤0.01% | 457 |
|
|
2020
Q3 | $59K | Hold |
1,538
| – | – | ﹤0.01% | 393 |
|
|
2020
Q2 | $54K | Buy |
1,538
+193
| +14% | +$6.95K | ﹤0.01% | 404 |
|
|
2020
Q1 | $44K | Hold |
1,345
| – | – | ﹤0.01% | 419 |
|
|
2019
Q4 | $61K | Buy |
1,345
+250
| +23% | +$10.5K | ﹤0.01% | 332 |
|
|
2019
Q3 | $45K | Buy |
1,095
+200
| +22% | +$8.47K | ﹤0.01% | 342 |
|
|
2019
Q2 | $38K | Sell |
895
-8
| -0.9% | -$308 | ﹤0.01% | 366 |
|
|
2019
Q1 | $35K | Buy |
903
+468
| +108% | +$17.9K | ﹤0.01% | 368 |
|
|
2018
Q4 | $15K | Sell |
435
-206
| -32% | -$7.47K | ﹤0.01% | 450 |
|
|
2018
Q3 | $25K | Hold |
641
| – | – | ﹤0.01% | 391 |
|
|
2018
Q2 | $21K | Hold |
641
| – | – | ﹤0.01% | 400 |
|
|
2018
Q1 | $18K | Hold |
641
| – | – | ﹤0.01% | 390 |
|
|
2017
Q4 | $16K | Hold |
641
| – | – | ﹤0.01% | 404 |
|
|
2017
Q3 | $19K | Hold |
641
| – | – | ﹤0.01% | 366 |
|
|
2017
Q2 | $18K | Hold |
641
| – | – | ﹤0.01% | 388 |
|
|
2017
Q1 | $16K | Hold |
641
| – | – | ﹤0.01% | 395 |
|
|
2016
Q4 | $14K | Hold |
641
| – | – | ﹤0.01% | 362 |
|
|
2016
Q3 | $15K | Hold |
641
| – | – | ﹤0.01% | 360 |
|
|
2016
Q2 | $15K | Hold |
641
| – | – | ﹤0.01% | 341 |
|
|
2016
Q1 | $12K | Hold |
641
| – | – | ﹤0.01% | 362 |
|
|
2015
Q4 | $12K | Hold |
641
| – | – | ﹤0.01% | 364 |
|
|
2015
Q3 | $11K | Hold |
641
| – | – | ﹤0.01% | 375 |
|
|
2015
Q2 | $11K | Hold |
641
| – | – | ﹤0.01% | 374 |
|
|
2015
Q1 | $11K | Buy |
+641
| New | +$10.1K | ﹤0.01% | 381 |
|
Other funds holding BSX
Allworth Financial's BSX Position: Q2 2026 in Review
Allworth Financial reduced its Boston Scientific (BSX) stake by 44% in Q2 2026, selling an estimated $1.4M and leaving 32,432 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #625.
Allworth Financial first reported a position in BSX in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.4M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Allworth Financial held 32,432 shares of Boston Scientific worth $1.38M as of Q2 2026.
- Allworth Financial sold 25,735 Boston Scientific shares in Q2 2026, an estimated $1.4M.
- Boston Scientific made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #625 holding.
- Allworth Financial first reported a position in Boston Scientific in Q1 2015 and has held it in 46 quarters since.
- Allworth Financial's Boston Scientific position peaked at $4.4M in Q4 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.